Suivre
Stian Knappskog
Stian Knappskog
Adresse e-mail validée de med.uib.no
Titre
Citée par
Citée par
Année
Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
Nature 500 (7463), 415-421, 2013
97292013
Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
Nature 500 (7463), 415-421, 2013
97292013
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
21602016
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1650*2020
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
LR Yates, M Gerstung, S Knappskog, C Desmedt, G Gundem, P Van Loo, ...
Nature medicine 21 (7), 751-759, 2015
8342015
Genomic evolution of breast cancer metastasis and relapse
LR Yates, S Knappskog, D Wedge, JHR Farmery, S Gonzalez, ...
Cancer cell 32 (2), 169-184. e7, 2017
6482017
Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes
JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ...
Science 345 (6196), 1251343, 2014
4362014
Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track–letter
A Torsvik, GV Røsland, A Svendsen, A Molven, H Immervoll, ...
Cancer research 70 (15), 6393-6396, 2010
3572010
Clinical effect of temozolomide‐based chemotherapy in poorly differentiated endocrine carcinoma after progression on first‐line chemotherapy
S Welin, H Sorbye, S Sebjornsen, S Knappskog, C Busch, K Öberg
Cancer 117 (20), 4617-4622, 2011
3222011
Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
S Nik-Zainal, DC Wedge, LB Alexandrov, M Petljak, AP Butler, N Bolli, ...
Nature genetics 46 (5), 487-491, 2014
3052014
Gene expression profiling–based identification of molecular subtypes in stage IV melanomas with different clinical outcome
G Jönsson, C Busch, S Knappskog, J Geisler, H Miletic, M Ringnér, ...
Clinical cancer research 16 (13), 3356-3367, 2010
2842010
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo
YS Ju, I Martincorena, M Gerstung, M Petljak, LB Alexandrov, R Rahbari, ...
Nature 543 (7647), 714-718, 2017
2762017
Corrigendum: Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, S Aparicio, S Behjati, ...
Nature 502 (7470), 258-258, 2013
2292013
Australian Pancreatic Cancer Genome I
LB Alexandrov, S Nik-Zainal, DC Wedge, SA Aparicio, S Behjati, ...
Consortium IBC, Consortium IM-S, PedBrain I, Zucman-Rossi J, Futreal PA …, 2013
2182013
The level of synthesis and secretion of Gaussia princeps luciferase in transfected CHO cells is heavily dependent on the choice of signal peptide
S Knappskog, H Ravneberg, C Gjerdrum, C Tröβe, B Stern, IF Pryme
Journal of biotechnology 128 (4), 705-715, 2007
1342007
Olaparib monotherapy as primary treatment in unselected triple negative breast cancer
HP Eikesdal, S Yndestad, A Elzawahry, A Llop-Guevara, B Gilje, ES Blix, ...
Annals of oncology 32 (2), 240-249, 2021
1312021
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians
S Knappskog, M Bjørnslett, LM Myklebust, PEA Huijts, MP Vreeswijk, ...
Cancer cell 19 (2), 273-282, 2011
1282011
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
M Smid, FG Rodríguez-González, AM Sieuwerts, R Salgado, ...
Nature communications 7 (1), 12910, 2016
1222016
EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation
E Eskilsson, GV Rosland, KM Talasila, S Knappskog, O Keunen, ...
Neuro-oncology 18 (12), 1644-1655, 2016
1032016
CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary …
R Chrisanthar, S Knappskog, E Løkkevik, G Anker, B Østenstad, ...
PloS one 3 (8), e3062, 2008
1022008
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20